Search

everythinglearnresearchcommunity

for

Search:↓

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

A man developed a rare scalp disorder, Folliculitis Decalvans, 20 years after hair restoration surgery, and it required long-term antibiotic treatment.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

A horse with severe hair loss was diagnosed with alopecia areata and a yeast infection.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Some horses lose hair without inflammation or itching due to various conditions, and while mainly a cosmetic issue, diagnosis requires examination and biopsies, and breeding is not advised if it's hereditary.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

The cornified envelope is crucial for skin's barrier function and involves key proteins and genetic factors.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Erdr1 could be a new marker for diagnosing hair loss.

Dermatologists often neglect hair disorders due to complexity and lack of clear treatments, impacting patient care and highlighting the need for better education and interest in this area.